HCA Healthcare, Inc. HCA is seeing higher patient volumes while patients are spending slightly less time in its hospitals. This combination could help the company use existing capacity more effectively as it continues to expand its network. In the second quarter of 2026, reported admissions increased 2.4% year over year to nearly 580,000. Same-facility admissions rose 2.5%, while same-facility emergency room visits advanced 3.6%.
At the same time, the average length of stay declined to 4.643 days from 4.726 days a year earlier. Occupancy improved to 72.7% from 72.0%, even as the average length of stay declined. This shows that HCA accommodated faster admission growth without a comparable increase in patient days. Patient days increased just 0.6%, considerably slower than admission growth.
The trend could become increasingly relevant as demand grows across the company’s markets and it continues investing in inpatient beds and emergency room capacity. HCA has approved more than $7 billion of capital expenditures expected to come online over the next three years, including 1,000 to 1,200 additional inpatient beds.
Still, shorter stays do not automatically translate into better operating performance. Service mix can influence the metric, while lower surgical volumes remain a consideration. For HCA, the key will be maintaining admission growth while managing hospital capacity without compromising care delivery. If that balance persists, shorter stays could give the company additional flexibility as patient volumes grow.
How Do Peers Compare?
HCA’s Medical peers, including Tenet Healthcare Corporation THC and Universal Health Services, Inc. UHS, are also seeing steady hospital demand.
Tenet reported a 2.6% increase in same-hospital adjusted admissions in the second quarter of 2026, while emergency room visits rose 2%. THC’s hospital surgeries declined 0.7%, but net patient service revenue per adjusted admission increased 3.3%, supporting a 22.3% rise in hospital adjusted EBITDA to $762 million.
Universal Health’s same-facility acute-care adjusted admissions increased 2.9%, while adjusted patient days rose 3.1%. Net revenue per adjusted admission advanced 3%, helping acute-care revenues grow 8.2%. UHS saw patient-day growth broadly track admissions, while HCA’s patient-day growth remained well below its admission growth.
HCA’s Price Performance, Valuation & Estimates
Shares of HCA Healthcare have gained 3.4% over the past year compared with the industry's 15.3% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, HCA trades at a forward price-to-earnings ratio of 13.91, down from the industry average of 16.67. HCA carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HCA’s 2026 earnings is pegged at $29.42 per share, implying a 4.3% jump from the year-ago period’s level.
Image Source: Zacks Investment Research
HCA currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HCA Healthcare, Inc. (HCA): Free Stock Analysis Report
Universal Health Services, Inc. (UHS): Free Stock Analysis Report
Tenet Healthcare Corporation (THC): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).